Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1985-12-16
1987-08-18
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530331, A61K 3743, C07K 508
Patent
active
046877592
ABSTRACT:
The invention relates to the peptides of the formula: ##STR1## in which: R represents hydrogen or a protecting group for the terminal amine group, such as t-butoxycarbonyl (Boc), benzyloxycarbonyl (Z) or lower alkanoyl;
REFERENCES:
patent: 3875137 (1975-04-01), Jones et al.
patent: 3896103 (1975-07-01), Hardy et al.
patent: 4012367 (1977-03-01), Mazur
patent: 4172130 (1979-10-01), Kisfaludy et al.
patent: 4530837 (1985-07-01), Charon et al.
Journal of Chemistry, vol. 28, No. 3, Mar. 11, 1985.
Chemical Abstracts, vol. 94, No. 9, Mar. 1981.
Bali Jean-Pierre
Castro Bertrand
Demarne Henri
Magous Richard
Martinez Jean
Centre National de la Recherche Scientifique "CNRS"
Phillips Delbert R.
Sanofi
LandOfFree
Tripeptide and tetrapeptide esters which inhibit gastric secreti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tripeptide and tetrapeptide esters which inhibit gastric secreti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tripeptide and tetrapeptide esters which inhibit gastric secreti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1117964